GLP-1 INTELLIGENCE
LIVEStay ahead of the GLP-1 market.
Clinical research, industry moves, and regulatory shifts — curated from the sources that matter. Updated hourly.
19 articles
Statins and blood pressure drugs changing health risks of obesity, study suggests
New research shows obesity patients over 40 are managing blood pressure and cholesterol as well as healthy-weight peers, but younger adults remain at risk.
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT).
STAT+: More signs that GLP-1s may help with peripheral artery disease
Anthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout
FTC Seeks Public Comment on Policy Statement Addressing AI Accuracy
The Federal Trade Commission is seeking public comment on a proposed policy statement addressing concerns that AI companies may be manipulating the bView Press Release
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
The U.S. Food and Drug Administration today approved TREGZI, the first regulatory T (Treg) cell-based immunotherapy for improving chronic graft-versus-host disease (GVHD)-free survival in adult patients with blood cancers undergoing allogeneic hematopoietic stem cell transplantat
STAT+: Investors double down on Bain-backed startup
FDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech news
FTC Secures Agreement with Havas to Restore Competition in the Digital Advertising Ecosystem
Today, the Federal Trade Commission, along with a coalition of states, scored another major victory in the fight against collusive conduct in the advertising industry. Advertising agency Havas Media Group USA LLC (Havas) has agreed to a proposed FTC order to resolve allegations t
FTC Requires Amazon to Pay $2.25 Million to Resolve Charges It Knowingly Violated the Fair Credit Reporting Act
FTC alleged that Amazon routinely denied requests from identity theft victims seeking records of fraudulent transactions made with their personal data Amazon will pay $2.25 million in civil penalties to settle Federal Trade Commission allegations that the online retail giant know
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
FDA announces the selection of seven companies to participate in the FDA PreCheck Pilot Program, a new initiative designed to boost American global competitiveness, strengthen domestic drug manufacturing, and improve the resilience of the U.S. drug supply chain.
A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management
For seniors, the change in policy will dramatically expand access to a revolutionary medication. But there are also significant risks. The post A Bridge to Nowhere? Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management appeared first on MedCit
FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would help protect the public health of Americans, including youth, by strengthening the agency’s ability to efficiently identify illegal foreign tobacco products — including youth-appealing e-
Case 18-2026: A 53-Year-Old Man with Leg Weakness, Pain, and Weight Loss
New England Journal of Medicine, Volume 394, Issue 24, Page 2460-2469, June 25, 2026.
FTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopolies
The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct.View Press Release
FTC Approves Final Consent Order in Pest-Control Noncompete Matter
The Federal Trade Commission finalized a consent order that requires Rollins Inc.—one of the largest pest-control companies in the United States—to stop enforcing noncompete agreements against more than 18,000 employees nationwide. View Press Release
Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere?
New England Journal of Medicine, Volume 394, Issue 24, Page 2385-2387, June 25, 2026.
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal
Proposed FTC order requires divestiture of four drug products to resolve anticompetitive concerns The Federal Trade Commission took action to protect American patients from higher drug costs by requiring Aurobindo Pharma Limited to divest four different generic drug products to c
FDA Approves First Single-Dose Generic Treatment for Influenza
The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.
Survodutide Once Weekly for the Treatment of Adults with Obesity
New England Journal of Medicine, Ahead of Print.
Ready to build your GLP-1 program?
NexaCare handles the operational layer so your clinic can focus on patient outcomes.
Book a Demo →